Objective: Over one third of all newly diagnosed cancers in Canada in 2010 were skin cancer, despite the fact that skin cancer is largely preventable by limiting ultraviolet radiation (UVR) exposure. Outdoor workers are at risk of exposure to UVR, yet the prevalence of exposure in Canada is unknown. The objective of this study was to estimate the number of outdoor workers in Canada.

Methods: Building on CAREX Canada methods, we used a combination of data in the original Finnish CAREX, an Australian skin cancer prevention workbook, career-selection websites, and published studies to flag jobs at high risk of exposure. We also created a category for moderate exposure, where workers were unlikely to spend their whole day outside. Adjustments were made for industry-driven exposure, and prevalence of exposure was assigned for all jobs. Prevalence data were linked to census data to derive the number of workers exposed to solar UVR.

Results: Over 1.5 million Canadian workers are exposed to solar UV at work, and approximately 897,000 of these were flagged as "high exposed" (outdoors > or =75% of the workday). The largest occupational groups were farmers, construction labourers, and landscapers. Proportions of the workforce exposed ranged by province, with 6.9% of workers exposed in Ontario, and up to 17.3% in Prince Edward Island.

Conclusions: Information on solar UVR exposure prevalence is needed for primary skin cancer prevention with regard to targeting of high-risk groups, priority setting, and better risk assessment. This study showed that solar UVR exposure is occurring on a large scale in Canada.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973601PMC
http://dx.doi.org/10.1007/BF03403817DOI Listing

Publication Analysis

Top Keywords

skin cancer
16
prevalence exposure
12
uvr exposure
12
workers exposed
12
exposure
9
ultraviolet radiation
8
radiation uvr
8
outdoor workers
8
risk exposure
8
cancer prevention
8

Similar Publications

Introduction: Musculocontractural Ehlers-Danlos syndrome (mcEDS) is a rare autosomal recessive connective tissue disorder caused by systemic depletion of dermatan sulfate. Symptoms characteristic of mcEDS include multiple contractures, fragile skin with subcutaneous bleeding, and hypermobile joints, which suggest difficulty in perioperative management. However, safe surgical techniques and perioperative management of this disorder remain unknown because of its rarity.

View Article and Find Full Text PDF

Objective:  Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy and it is currently intractable We compared the efficacy of transcutaneous electrical acupoint stimulation (TEAS) against non-TEAS groups and investigated the variables that predict effective relief of upper extremity pain in cancer survivors with CIPN.

Methods: We retrospectively collected data of cancer survivors who developed CIPN between May 2017 to March 2022. All eligible CIPN patients were divided into TEAS group (received TEAS) and non-TEAS group (did not receive TEAS) in our department.

View Article and Find Full Text PDF

A Multifunctional MIL-101-NH(Fe) Nanoplatform for Synergistic Melanoma Therapy.

Int J Nanomedicine

January 2025

Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.

Background: Melanoma is an aggressive form of skin cancer, and single-modality treatments often fail to prevent tumor recurrence and metastasis. Combination therapy has emerged as an effective approach to improve treatment outcomes.

Methods: In this study, we developed a multifunctional nanoplatform, MIL@DOX@ICG, utilizing MIL-101-NH(Fe) as a carrier to co-deliver the chemotherapeutic agent doxorubicin (DOX) and the photosensitizer indocyanine green (ICG).

View Article and Find Full Text PDF

We examined the risk of subsequent malignant neoplasms (SMNs) in 1720 patients with hematologic cancers given allogeneic hematopoietic grafts from 03/1998 to 08/2023 after nonmyeloablative conditioning regimens. With a median follow-up of 12 years, the cumulative incidence of SMNs was 17% (95% CI, [15%, 19%]). Most SMNs (n = 543) were non-melanoma skin cancers seen in 208 patients; unfortunately, information on these cancers was not available in the Surveillance, Epidemiology, and End Results (SEER) database for comparison with such tumors in the general population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!